Breakpoint Therapeutics aims to advance the medical improvement of initial-in-class oncology medication that interfere with DNA restore and replication stress tolerance pathways. The company’s therapeutics target the DNA destruction reaction in cancer cells with restore and replication tension tolerance pathways, enabling the healthcare organisation and hospitals to establish prescrip... https://is.gd/VVmTMJ